What is the recommendation for CVD risk assessment for patients with intermediate CVD risk or with a new CVD risk factor?
It is recommended that patients with intermediate CVD risk or with appearance of a new CVD risk factor (e.g., new diagnosis of type 2 diabetes mellitus [DM] or hypertension) and not on statin therapy should have their CVD risk assessed every two years.